NOT_YET_RECRUITING

Skills for Talking About Cannabis for Families of Young Adults With Psychosis

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The objectives of this research is to (1) create a family intervention and provider manual to train family members of young people with psychosis (YP-P) who are heavy cannabis users new communication skills to motivate change in the YP-P's cannabis use, (2) pre-test the intervention with 10 family member participants and adapt the intervention based on their recommendations, and (3) evaluate the feasibility and acceptability of the intervention in a randomized pilot trial (n=40). The investigators anticipate that the intervention will improve family participants' communication skills, decrease expressed emotion and caregiver burden. The investigators anticipate that improvements in communication skills, expressed emotion and caregiver burden will lead to decreases in the cannabis use of their YP-P.

Official Title

Talking About Cannabis: Developing an Intervention for Family Members of Young Adults With FEP to Support Reduced Cannabis Use

Quick Facts

Study Start:2025-10-31
Study Completion:2027-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:NOT_YET_RECRUITING

Study ID

NCT06961877

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. aged 18 years or older,
  2. 2. has a loved one who is both in CSC treatment for FEP and has used cannabis on at least 9 days in the past 30,
  3. 3. has at least 10 hours of contact per week with their loved one with FEP. It is assumed that YA-P will be aged 13-40 with schizophrenia spectrum disorder given criteria for CSC enrollment.
  1. 1. Unable to read study materials and communicate feedback in English
  2. 2. Do not have access to Zoom

Contacts and Locations

Study Contact

Denise Walker, Ph.D.
CONTACT
602-496-1735
denise.walker@asu.edu
Ty Tristao, BA
CONTACT
(503) 451-3725‬
tt88@uw.edu

Principal Investigator

Denise Walker, Ph.D.
PRINCIPAL_INVESTIGATOR
Arizona State University

Study Locations (Sites)

The University of Washington
Seattle, Washington, 98195
United States

Collaborators and Investigators

Sponsor: University of Washington

  • Denise Walker, Ph.D., PRINCIPAL_INVESTIGATOR, Arizona State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-10-31
Study Completion Date2027-07

Study Record Updates

Study Start Date2025-10-31
Study Completion Date2027-07

Terms related to this study

Keywords Provided by Researchers

  • coordinated specialty care
  • cannabis use disorder
  • first episode psychosis
  • caregiver burden
  • cannabis use
  • communication skills

Additional Relevant MeSH Terms

  • Caregiver Burden
  • Cannabis Use
  • Expressed Emotion
  • Communications Skills